Print this page

Observations placeholder

Kalbitor

Identifier

019231

Type of spiritual experience

Hallucination (3)

A description of the experience

Ecallantide (trade name Kalbitor, investigational name DX-88) is a drug used for the treatment of hereditary angioedema (HAE) and in the prevention of blood loss in cardiothoracic surgery It is an inhibitor of the protein kallikrein and a 60-amino acid polypeptide which was developed from a Kunitz domain through phage display to mimic antibodies inhibiting kallikrein.

The most common adverse effects are headache, nausea, fatigue and diarrhea. Less common, but observed in more than 5% of patients in clinical trials, are respiratory tract infections, fever, vomiting, itching and upper abdominal pain. Up to 4% of patients showed anaphylaxis, which led to a black box warning in the US.

On Dec, 21, 2016 1,050 people reported to have side effects when taking Kalbitor.
Among them, 3 people (0.29%) have Hallucination

Time on Kalbitor when people have Hallucination :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Hallucination 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

 

On Dec, 3, 2015: 108 people reported to have side effects when taking Kalbitor. Among them, 1 people (0.93%) has Death.

Time on Kalbitor when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

 

 

The source of the experience

eHealthme

Activities

Observation contributed by: Julie Usher